Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment.
about
Nonalcoholic fatty liver disease as a multi-systemic diseaseOxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisNOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.Characterization of primary symptoms leading to Chinese patients presenting at hospital with suspected obstructive sleep apnea.The polymorphic and contradictory aspects of intermittent hypoxiaEffects of first-time overnight CPAP therapy for increasing the complexity of the patient's physiological system.Combined effects of sleep disordered breathing and metabolic syndrome on endothelial function: the Wisconsin Sleep Cohort studyNitric Oxide Bioavailability in Obstructive Sleep Apnea: Interplay of Asymmetric Dimethylarginine and Free Radicals.Obstructive Sleep Apnea, Oxidative Stress, and Cardiovascular Disease: Evidence from Human Studies.Oxidative stress parameters and their correlation with clinical, metabolic and polysomnographic parameters in severe obstructive sleep apnea syndrome.Patients with Obstructive Sleep Apnea Display Decreased Flow-Mediated Dilatation: Evidence from a Meta-Analysis.P2X7 Receptor Antagonism Attenuates the Intermittent Hypoxia-induced Spatial Deficits in a Murine Model of Sleep Apnea Via Inhibiting Neuroinflammation and Oxidative Stress.Cumulative Hypoxemia During Sleep Predicts Vascular Endothelial Dysfunction in Patients With Sleep-Disordered BreathingEffect of Continuous Positive Airway Pressure on Cardiovascular Biomarkers: The Sleep Apnea Stress Randomized Controlled Trial.Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver.Serum high-density lipoprotein correlates with serum apolipoprotein M and A5 in obstructive sleep apnea hypopnea syndrome.Chronic intermittent hypoxia and hypertension: a review of systemic inflammation and Chinese medicine.Beneficial role of vitamin D3 in the prevention of certain respiratory diseases.Is there a clinical role for oxidative stress biomarkers in atherosclerotic diseases?Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.OSA and cardiometabolic risk: What's the bottom line?Salivary markers of oxidative stress in patients with obstructive sleep apnea treated with continuous positive airway pressure.Epigenetic memory of oxidative stress: does nephrilin exert its protective effects via Rac1?8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnoea patients.Erythrocyte sedimentation rate may help predict severity of obstructive sleep apnea.Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS.Blood trace minerals concentrations and oxidative stress in patients with obstructive sleep apnea.NADPH Oxidase Deficiency: A Multisystem Approach.
P2860
Q26749290-AE338842-8F05-433B-835B-2AE89753605EQ28084150-C4192803-686E-4C22-949D-54202CBA0E41Q33583595-BC9DEF89-723A-4747-8650-DEDDA80D9A37Q33586034-9D1EC286-F776-48AB-B7D1-4D06FB36CE1AQ33913792-9B6940AA-2915-4CB9-9284-80A7A6B5A202Q34029688-80C2FC65-9764-4A87-9702-D550C8573012Q34238363-77075A36-DDEA-485B-BD65-31262B70AD16Q35625951-0DEB3C64-37B7-414C-B6BA-B3436B433655Q35763744-CD978F33-9D00-4CEF-A4FC-985D17747AF5Q36046739-637F2C41-BE03-4AD4-A532-5157E1F6F8C9Q36292710-CF83066F-14B0-42FB-9B96-BC8386B8ABC7Q36477283-7819A8A3-0EB0-41DC-A281-783869DFA01BQ36950166-97DE8070-755B-492D-B7A7-5CD1AFBD1214Q37166381-B6533A69-8E18-472E-A830-3D559DBAC680Q37616138-A470DA73-836B-4CBB-9B95-7F0F51E17BD9Q37689584-8EA4B246-0BF2-40A6-BEAA-E6E303DF5938Q38106888-6C34732B-D09B-438E-B3B4-637B68F6D594Q38140574-992EEE1F-F911-4683-AA8E-5AD58E00673DQ38140700-5507B3EA-2377-44AF-967E-CE93F630EE3AQ38919168-7FD13DC8-09C1-4088-8930-F30FC208C7A3Q39120083-4B7100AB-00B1-49F3-B192-BB9CAA537808Q39298171-B5FF9EED-F182-45F0-AB60-35807E6F17C4Q41096130-BDF61E09-D0F1-434F-99BB-64FE889DA3ACQ47850203-87E143C3-EDBD-4CFD-AB56-89413999BAF0Q47942648-99E9F280-FC78-47AC-81FE-595DDCE15889Q48131006-E4F0F699-D58D-475C-B998-F5826739318BQ48151679-79CBC842-EE7C-44EA-BF7C-7E07197E8FEEQ49422978-239906E2-EA4B-48C4-8222-0F9BB9A42338
P2860
Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Oxidative stress mediated arte ...... ive airway pressure treatment.
@ast
Oxidative stress mediated arte ...... ive airway pressure treatment.
@en
Oxidative stress mediated arte ...... ive airway pressure treatment.
@nl
type
label
Oxidative stress mediated arte ...... ive airway pressure treatment.
@ast
Oxidative stress mediated arte ...... ive airway pressure treatment.
@en
Oxidative stress mediated arte ...... ive airway pressure treatment.
@nl
prefLabel
Oxidative stress mediated arte ...... ive airway pressure treatment.
@ast
Oxidative stress mediated arte ...... ive airway pressure treatment.
@en
Oxidative stress mediated arte ...... ive airway pressure treatment.
@nl
P2093
P2860
P50
P356
P1476
Oxidative stress mediated arte ...... ive airway pressure treatment.
@en
P2093
Fabiana Albanese
Francesco Angelico
Licia Polimeni
Marco Brunori
Maria Del Ben
Mario Fabiani
Teresa Augelletti
P2860
P2888
P356
10.1186/1471-2466-12-36
P577
2012-07-23T00:00:00Z
P5875
P6179
1022022138